- Home
- GDDY vs RVMD Comparison
GDDY vs RVMD Comparison
Compare GDDY & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDDY | RVMD |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 15.2B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GDDY | RVMD |
|---|---|---|
| Price | $119.97 | $79.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $183.54 | $77.47 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 02-12-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.80 | N/A |
| Revenue | ★ $4,869,800,000.00 | N/A |
| Revenue This Year | $10.25 | N/A |
| Revenue Next Year | $6.94 | $714.50 |
| P/E Ratio | $20.45 | ★ N/A |
| Revenue Growth | ★ 8.68 | N/A |
| 52 Week Low | $117.19 | $29.17 |
| 52 Week High | $216.00 | $81.97 |
Technical Indicators
Market Signals| Indicator | GDDY | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.56 | 61.62 |
| Support Level | $117.19 | $76.28 |
| Resistance Level | $127.61 | $80.48 |
| Average True Range (ATR) | 2.32 | 2.33 |
| MACD | -0.66 | -0.65 |
| Stochastic Oscillator | 26.13 | 76.67 |
Price Performance
Historical ComparisonAbout GDDY GoDaddy Inc.
GoDaddy provides a comprehensive portfolio of solutions to help entrepreneurs manage their company's digital presence. In particular, GoDaddy helps customers establish websites, attract customers, and generate revenue. It operates through two segments—the core platform and applications and commerce. The core platform consists of domain registration services as well as hosting and security services. The newer applications and commerce segment consists of website design, marketing tools, and payment services. As of fiscal 2024, the company had over 20,000 customers and greater than 80 million domains under management.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.